RNA dimmer switch helps mice survive lethal sepsis, study finds
UC Santa Cruz researchers found Gaplinc, a long noncoding RNA, works like a dimmer switch inside immune cells, tuning both inflammation and metabolism. Mice stripped of it survived lethal doses of bacterial toxin that killed normal mice. The team says targeting it could give doctors a new way to treat sepsis, a disease with few options beyond fluids and antibiotics.
- Original source: medicalxpress.com.
- The source published it on Nov 17, 2026 at 1:40 PM.
- Not verified by major outlets. This story may be false.
- No second outlet has reported it yet. Treat it as a single-source claim.
The mechanism is a long noncoding RNA called Gaplinc, which lives in macrophages — the immune cells that sound the alarm during infection. According to the UC Santa Cruz team behind the work, Gaplinc latches onto an enzyme named MCCC1 inside mitochondria, the cell's energy factories, effectively wiring gene expression to metabolic processing. When the researchers deleted the molecule entirely in mice, baseline immune genes sat slightly 'pre-armed' and circulating blood fats tipped into a protective, sepsis-resistant balance.
The payoff was stark: every Gaplinc-deficient mouse survived lethal levels of bacterial toxin that proved fatal to normal mice. Losing the RNA boosted helpful lipids called lysophosphatidylcholines and pared back toxic free fatty acids. Push Gaplinc too far the other way — overproducing it — and baseline immune readiness sank so low the animals became far more vulnerable to swift, fatal shock. It behaves as a rheostat, not an on-off switch.
The stakes are enormous. Sepsis kills at least 20% of adults and 10% of children who develop it, according to the CDC, and the agency counts it in one out of every three hospital deaths nationwide. The condition is behind at least 350,000 adult deaths and more than 1,800 child deaths each year during hospitalization or after transfer to hospice. Clinicians today have little beyond fluids, antibiotics and supportive care once runaway inflammation starts damaging healthy organs.
Senior author Susan Carpenter, a professor of molecular, cell and developmental biology at UC Santa Cruz and co-director of the UCSC RNA Center, framed the appeal of a gentler approach. 'Sepsis is devastating because once that inflammatory cascade spirals out of control, clinicians mostly have to rely on supportive care and hope the patient can weather the storm,' she said. Rather than shutting the immune system down and leaving patients exposed to the underlying infection, she said, 'targeting Gaplinc could let us fine-tune the body's metabolic resilience to survive the shock.'
The work, a collaboration published in the Proceedings of the National Academy of Sciences, points toward transient RNA therapeutics — lipid nanoparticles, for instance — that could temporarily rebalance Gaplinc levels and reprogram metabolism during an acute infection. Carpenter's lab first found that the RNA regulates key inflammatory genes driven by a specific protein complex; the new paper, she said, 'expands this foundation by demonstrating how Gaplinc operates across systemic organ networks and metabolic pathways.'
TopicsGaplinc · UC Santa Cruz · Susan Carpenter · MCCC1 · Proceedings of the National Academy of Sciences · CDC · UCSC RNA Center · lipid nanoparticles
Source: medicalxpress.com
Written by AI from verified reporting.
More stories
- Health & science scitechdaily.com 0 viewsFDA Clears Teplizumab for Kids Newly Diagnosed With Type 1 Diabetes
- Health & science inquirer.com Caught by @Midas👑 0 viewsCDC Study Finds 112 Pregnant Women and 13 Newborns Sickened by Measles
- Health & science theguardian.com 0 viewsEuropean Pesticides Named in 1,605 Brazil Poisoning Reports
- Health & science theepochtimes.com 0 viewsFDA Refuses to Approve Akeso-Summit Lung Cancer Drug After Survival Miss

